Alabama Nursing Board Defense Lawyer – Call Today – Physician who survived Ebola received experimental drug treatment – (866) 348-2889
A Ugandan physician, who contracted Ebola in Sierra Leone, survived after being flown to Germany for aggressive treatment involving a new drug, FX06 — a fibrin-derived peptide under clinical development for vascular leakage, according to an article published Dec. 19 in The Lancet.
The 38-year-old physician, who was in charge of an Ebola virus treatment unit in Lakka, Sierra Leone, tested positive for Ebola on Sept. 28. The doctor was airlifted to Frankfurt University Hospital on the fifth day of his illness and admitted to a special isolation unit. Within three days, he developed signs of vascular leakage and severe multi-organ failure, including the lungs, kidneys and gastrointestinal tract. He was placed on a ventilator and on kidney dialysis, and was given antibiotics together with a three-day course of FX06, which has been shown to reduce vascular leakage and its complications in mice with Dengue hemorrhagic shock.